Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

AGP Ltd (AGPL)

Karachi
Currency in PKR
Disclaimer
81.80
+1.34(+1.67%)
Closed
AGPL Scorecard
Trading near 52-week High
Fair Value
Unlock Value
Day's Range
80.0082.95
52 wk Range
46.0082.95
Bid/Ask
81.60 / 81.80
Prev. Close
80.46
Open
82.95
Day's Range
80-82.95
52 wk Range
46-82.95
Volume
197,960
Average Volume (3m)
121,457
1-Year Change
56.7%
Shares Outstanding
280,000,000
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell

People Also Watch

136.55
PION
-0.76%
109.26
TAGS
+1.87%
30.16
PKRF
+3.04%
70.99
INTR
+0.13%
How do you feel today about AGPL?
Vote to see community's results!
or

AGP Ltd Company Profile

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antipsychotics, biguanide and S-urea combs, bile stone therapy, calcium, calcium channel blocker, cephalosporins oral and inject, DPP-IV Inh and biguanide comb, DPP-IV Inh A-diab plain, expectorants, eye tonics and eye vitamins, fluoroquinolones, glitazone and S-urea combs, glitazone A-diabs plain, glitazone and biguanide combinations, hepatitis C antivirals, iron combination products, iron plain, lipid modifying agents combinations, menthae piperitae aetheroleum, muscle relaxants central, narcotic analgesic, and non-narcotic analgesic. It provides narcotic analgesic, non-narcotic analgesics, nucleoside reverse transcriptase inhibitors, Oth anti-anaem folic acid, other musculoskeletal products, other stomach disorder products, proton pump inhibitor, psycholeptic antidepressant, SGLT2 inhibitors antidiabetic and biguanide, sitagliptin, SSRI antidepressants, sulphonylurea, systemic vasoprotectives, tonic, topical antihaemorrhoidal, urinary anti-infectives, urinary incontinence prd, vitamin B12, vitamin B12 plain, vitamin C combinations, vitamin D3, and xanthine-systemic products. AGP Limited was founded in 1989 and is headquartered in Karachi, Pakistan. AGP Limited operates as a subsidiary of Merck Sharp & Dohme of Pakistan Limited.

Employees
1574
Market
Pakistan
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.